Trident Texofab Limited

BSE:540726 Stock Report

Market Cap: ₹1.6b

Trident Texofab Management

Management criteria checks 3/4

Trident Texofab's CEO is Hardik Desai, appointed in Jun 2017, has a tenure of 7.58 years. total yearly compensation is ₹2.20M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 21.08% of the company’s shares, worth ₹332.25M. The average tenure of the management team and the board of directors is 2 years and 6.9 years respectively.

Key information

Hardik Desai

Chief executive officer

₹2.2m

Total compensation

CEO salary percentage100.0%
CEO tenure7.6yrs
CEO ownership21.1%
Management average tenure2yrs
Board average tenure6.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Hardik Desai's remuneration changed compared to Trident Texofab's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹22m

Jun 30 2024n/an/a

₹19m

Mar 31 2024₹2m₹2m

₹11m

Dec 31 2023n/an/a

₹12m

Sep 30 2023n/an/a

₹18m

Jun 30 2023n/an/a

₹19m

Mar 31 2023₹2m₹2m

₹22m

Dec 31 2022n/an/a

₹28m

Sep 30 2022n/an/a

₹18m

Jun 30 2022n/an/a

₹11m

Mar 31 2022₹2m₹2m

₹10m

Dec 31 2021n/an/a

₹9m

Sep 30 2021n/an/a

₹9m

Jun 30 2021n/an/a

₹10m

Mar 31 2021₹1m₹1m

₹4m

Dec 31 2020n/an/a

₹728k

Sep 30 2020n/an/a

₹2m

Jun 30 2020n/an/a

₹2m

Mar 31 2020₹2m₹2m

₹9m

Dec 31 2019n/an/a

₹9m

Sep 30 2019n/an/a

₹10m

Jun 30 2019n/an/a

₹12m

Mar 31 2019₹2m₹2m

₹13m

Dec 31 2018n/an/a

₹12m

Sep 30 2018n/an/a

₹11m

Jun 30 2018n/an/a

₹8m

Mar 31 2018₹720k₹720k

₹8m

Compensation vs Market: Hardik's total compensation ($USD25.41K) is below average for companies of similar size in the Indian market ($USD41.56K).

Compensation vs Earnings: Hardik's compensation has increased by more than 20% in the past year.

CEO

Hardik Desai (46 yo)

7.6yrs

Tenure

₹2,200,000

Compensation

Mr. Hardik Jigishkumar Desai serves as Chairman of Trident Lifeline Pvt. Ltd., since June 27, 2022 and its Executive Director since October 01, 2020. He has been Managing Director of Trident Texofab Limite...

Leadership Team

NamePositionTenureCompensationOwnership
Hardik Desai
MD & Executive Chairman7.6yrs₹2.20m21.08%
₹ 332.3m
Chetan Jariwala
Whole-Time Directorno data₹1.20m15.48%
₹ 244.0m
Manish Halwawala
Executive & Non-Independent Directorno data₹660.00k0.65%
₹ 10.2m
Jenish Jariwala
Chief Financial Officerless than a yearno datano data
Rahul Jariwala
Company Secretary & Compliance officer2yrsno datano data

2.0yrs

Average Tenure

46.5yo

Average Age

Experienced Management: 540726's management team is considered experienced (2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Hardik Desai
MD & Executive Chairman16.3yrs₹2.20m21.08%
₹ 332.3m
Chetan Jariwala
Whole-Time Director11.9yrs₹1.20m15.48%
₹ 244.0m
Manish Halwawala
Executive & Non-Independent Director4.2yrs₹660.00k0.65%
₹ 10.2m
Ankita Saraiya
Non-Executive & Independent Director6.9yrs₹24.00kno data
Mishal Patel
Independent & Non-Executive Director1.4yrsno datano data

6.9yrs

Average Tenure

46yo

Average Age

Experienced Board: 540726's board of directors are considered experienced (6.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 19:56
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Trident Texofab Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution